Dysautonomia Clinic

07/28/2025

💥 We are incredibly excited to have Dr. Bonnie Floyd, PhD, a clinical psychologist, join our Dysautonomia Clinic Team! Dr. Floyd received her PhD in Clinical Health Psychology from Albert Einstein College of Medicine because it combined her dual interests in clinical psychology and medicine.

Dr. Floyd is uniquely trained in assisting patients who have been diagnosed with chronic illness to have the best possible quality of life. As a patient herself with multiple sclerosis, Dr. Floyd has written a book, “Remarkable Journey: My Dual Diagnoses as Doctor and Patient,” which describes her professional and personal experiences of living with a chronic medical condition.

Dr. Floyd is scheduling patients of Dysautonomia Clinic for September 2025. If you'd like to schedule an appointment with Dr. Floyd, please e-mail to admin@amherstneurology.com. 🧠

http://www.dysautonomiaclinic.com/meet-the-team/

07/22/2025

‼️ Read this paper describing a large case series of patients with mast cell activation syndrome (MCAS) and comorbidities, whose MCAS-associated symptoms improved significantly on GLP1 agonists.

📌 To summarize:
✔️ 47 patients (mean age 39, range 15–71, 89% female) included - all from the co-authors who are experts in MCAS and comorbidities, including from our Dysautonomia Clinic!
✔️ 89% of patients demonstrated clinical benefit with GLP-1RAs for a broad range of problems associated with MCAS.
✔️ Obviously, GLP-1RAs were used for overweight, obesity, type 2 DM and off label by patients who could afford them.
✔️ No major adverse events occurred, GLP-1RAs were well-tolerated in this case series
✔️ Randomized controlled trials are needed to determine whether GLP-1RAs are effective - and at what dose - in patients with MCAS.

https://www.sciencedirect.com/science/article/pii/S0002962925011061?dgcid=coauthor

07/15/2025

💥 This past weekend at in Raleigh, NC, Dr. Blitshteyn gave a CME lecture on headache management in patients with dysautonomia. The lecture included new, cutting-edge treatment and concepts in and and was very well-received. Thanks to Dysautonomia International for organizing a great conference and CME course for healthcare practitioners! 🎉

07/08/2025

‼️ NEW PAPER: Dysautonomia: a common comorbidity of systemic disease. Read Dr. Blitshteyn's full-length article here: 👇
https://link.springer.com/article/10.1007/s12026-025-09661-2

07/03/2025

‼️ HOT OFF THE PRESS: A groundbreaking study on neuropsychiatric disorders in mast cell activation syndrome (MCAS) has been published! We are honored to be one of the centers that participated in this study. The most common comorbidity of MCAS was POTS affecting 50% of female patients and 16% of male patients. 🧠🩺
Read full-length article here: 👇
https://www.sciencedirect.com/science/article/pii/S2666354625001061

05/23/2025

Congratulations to Dr. Blitshteyn on being recognized as a 2025 Research All-Star in Neurology, ranking in the Top 3% nationwide!

This honor by Avant-Garde Health is in recognition of the quantity and quality of peer-reviewed research publications and includes only the top 5% of physicians publishing leading-edge research in Neurology care.

05/21/2025

In this Letter to the Editor to the British Medical Journal, an international group of outstanding researchers and clinicians specializing in , including Dr. Blitshteyn, discusses the science of ME/CFS and the need for effective therapies backed by robust clinical trials, not opinions. You cannot think yourself out of any chronic medical condition!

Read full article here: 👇
https://www.bmj.com/content/389/bmj.r977/rr-16

05/14/2025

Great to see Newsweek talking about POTS! Dr. Blitshteyn was interviewed for this article.

05/10/2025

🎉🌟 Yesterday we had our annual Dysautonomia Clinic Research Party! We are so proud of our amazing Jacobs School of Medicine & Biomedical Sciences - University at Buffalo medical students and future neurologists. They have done outstanding work by moving the science of , POTS, , and forward. Every year we have more and more students join our Dysautonomia Clinic Research Team because we do cutting-edge innovative research that leads to tangible results that are published in scientific journals and presented at the national meetings. 🧠👩‍🔬🔬

05/08/2025

‼️ Drs. Svetlana Blitshteyn and Nancy Smyth' paper on how to communicate with patients with complex chronic disorders has been highlighted in the University at Buffalo press release. Read here: 👇
https://www.buffalo.edu/news/releases/2025/04/Clinicians-communicate-patients-complex-disorders.html

05/01/2025

‼️ Drs. Blitshteyn and Smyth' recent paper on what not to say to people with complex has been highlighted by various media outlets, including Medscape. Read Dr. Blitshteyn's interview here: 👇
https://www.medscape.com/viewarticle/what-not-say-people-complex-chronic-illness-2025a10006ft

04/29/2025

🌎 A global consensus paper of 179 healthcare experts from 28 different countries highlights that is a major public health issue with significant adverse health, economy and societal impacts. Dr. Blitshteyn, a co-author on this paper, serves on the World Health Network Executive Committee that spearheaded this project. 🩺🦠🔬

Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There are few recommendations, and no formal training exists for medical professionals to assist with clinical evaluation and management of patients with Long COVID. More research into the...